Endometrial Undifferentiated Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-21
Clinical Trial Update: Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma [Phase 2]
This Phase 2 trial investigates nivolumab with or without ipilimumab in mismatch repair–deficient (dMMR) recurrent endometrial cancer and is…